Katrien Eeckhout

katrien eeckhout

As a 3rd year trainee in laboratory medicine at the Antwerp University, I’m very thankful that I received the EFLM bursary. After my graduation in Master of Medicine, I chose laboratory medicine because of the broad spectrum of pathologies, the continuous evolutions and the opportunity to combine a clinical specialty with (people) management and research. Therefore, I’m very grateful for the research opportunities and the support from Dr. Khadija Guerti (MD, clinical biology- immunology- allergology-protein chemistry, Antwerp University Hospital) and her laboratory team.

 

Since I started as a laboratory medicine trainee, I always went with a lot of enthusiasm to the annual national congress of the Royal Belgian Society for Laboratory Medicine (RBSLM). This year they made publicity for the EFLM congress 2019 in Barcelona. When I saw the program of this 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine I was very interested. On the website of the congress, I saw many interesting topics that in my opinion are very educational for trainees as me.

I am convinced that the broad range of topics (from point of care testing to ethical issues in the laboratory and answering the question “who should lead a laboratory”) are going to contribute to my training in laboratory medicine. I am looking forward to gather knowledge about these very interesting subjects. Therefore, I submitted 3 abstracts in for this congress and was very delighted that they all were accepted. I am very proud to present my research projects at the 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine.

List in the below table the abstract(s) submitted for the EuroMedLab 2019 as First Author:

  Title of the abstract(s)
1. Evaluation of three commercially available ELISA kits for the determination of chromogranin A.
K. Eeckhout, K. Van Cotthem, B. Peeters, K. Guerti.
2. Anti-NMDA encephalitis after vaccination: a case report.
K. Eeckhout, K. Van Cotthem, K. Guerti.
3. How to deal with samples with errors on APTT, PT and fibrinogen due to optical clot detection?
K. Eeckhout, J. Van Den Bossche, K. Deiteren, R. Malfait, MB. Maes